FDA Inspection
Bioreliance Ltd.Bioreliance Ltd. – FDA Inspection, Mar 15, 2019
Record Details
This FDA Inspection record concerns Bioreliance Ltd., with an inspection on March 15, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 6d908b43-3b15-436a-839a-aaef7318e1d3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1093195
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Bioreliance Ltd.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| December 5, 2025 | Not classified | Office of Inspections and Investigations | |
| November 7, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| March 17, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bioreliance Ltd.
- FDA Inspection 1288500 - 2025-12-05
- FDA Inspection 1225550 - 2023-11-07
- FDA Inspection 1202961 - 2021-03-17
- FDA Inspection 1108960 - 2019-09-27
- FDA Inspection 1026860 - 2017-09-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.